CBG

Many people already know that the hemp plant has a broad range of cannabinoids in it, such us: Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), etc. More well-known cannabinoids are CBD and THC, but recently research attention has caught studying one of the cannabinoids - Cannabigerol (CBG), one of the most expensive cannabinoids to produce. Researches have found CBG in a low concentration in mature cannabis flowers. CBG is like the other cannabinoids' ancestor, which means that all cannabinoids occur as CBG and ultimately convert to other cannabinoids like THC or CBD. CBD and CBG are both does not have psychoactive effects. According to various studies, both connect with the same receptors in our bodies and can have anti-inflammatory effects. Also, CBG can interact with many different receptors in our bodies more directly and effectively than CBD. There is still minimal research on CBG, but the studies show that using CBG can positively influence appetite loss, inflammatory bowel disease, bladder dysfunctions, glaucoma, bacterial infections, Huntington's disease, cancer. It must be remembered that CBG is still under research, and there is still much to be learned about it. However, the initial studies are quite promising.

CBG Benefits

Emerging research points to potential therapeutic benefits of CBG (cannabigerol), though further studies are required to confirm these effects. Here are some notable early insights:

Cancer Research: A meta-analysis conducted in 2021 suggests that CBG may slow the proliferation of breast cancer cells and might even destroy inflammatory cells linked to cancer growth.

Mood and Mental Health: In a smaller-scale investigation, the primary motivation for individuals using cannabis products rich in CBG was to alleviate anxiety, with a third also using it to manage depression. Many participants reported that CBG surpassed standard medications in effectiveness for these mental health concerns.

Inflammatory Bowel Conditions (IBD): According to one review, between 15% and 40% of those suffering from IBD turn to cannabis or cannabinoids to enhance appetite and alleviate discomfort. While initial research suggests possible benefits for IBD management, experts stress the need for more robust studies to determine optimal dosage and usage methods.

Persistent Pain: The same research highlighted chronic pain as the second-leading reason for CBG consumption, with 73.9% of respondents asserting that it outperformed conventional pain relief options. Persistent pain, defined as lasting over three months, affects around 51.6 million adults in the U.S., roughly 20% of the population.

Neurodegenerative Disorders: Huntington’s disease, a condition that causes the progressive breakdown of nerve cells in the brain, may benefit from CBG’s neuroprotective properties. CBG appears to shield certain brain cells (N2a cells) from damage caused by overstimulation of neurotransmitters, improving cell longevity.

Eye Pressure and Glaucoma: Elevated intraocular pressure (IOP) can increase the likelihood of developing glaucoma. Several studies indicate that cannabinoids, including CBG, may help reduce IOP in both human and animal subjects, potentially positioning it as a treatment for glaucoma-related issues.

Antibacterial Potential: In 2020, a study discovered that CBG possesses antibacterial qualities, especially effective against methicillin-resistant Staphylococcus aureus (MRSA), a type of staph infection that is resistant to many common antibiotics.